A study on patients with allergic asthma also supported the notion that TL1A interactions with DR3 on ILC2s may contribute to this disease: allergen challenges not only increased the TL1A levels in the airways but also elevated DR3 expression in lung ILC2s125. This evidence concerns the gene TNFRSF25 and allergic asthma.